Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis

Clinical Radiology

Volumn 69, Issue 1, 2014, Pages 1-10

  Lim, K S ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

YTTRIUM 90;

CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER THERAPY; CELL DEDIFFERENTIATION; CHEMOEMBOLIZATION; DIFFUSION WEIGHTED IMAGING; HUMAN; INTERMETHOD COMPARISON; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HISTOLOGY; LYMPH VESSEL METASTASIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOFREQUENCY ABLATION; REVIEW; SATELLITE METASTASIS; SYSTEMIC THERAPY; TREATMENT RESPONSE; VISIBILITY;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84891042782     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2013.07.022     Document Type: Review

References (60)

1. J. Bruix, M. Sherman, and J.M. Llovet et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
2. A. Colli, M. Fraquelli, and G. Casazza et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review Am J Gastroenterol 101 2006 513 523
3. N.L. Kelekis, R.C. Semelka, and S. Worawattanakul et al. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images AJR Am J Roentgenol 170 1998 1005 1013
4. G. Piana, L. Trinquart, and N. Meskine et al. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases J Hepatol 55 2011 126 132
5. A. Forner, R. Vilana, and C. Ayuso et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma Hepatology 47 2008 97 104
6. L. Bolondi, S. Gaiani, and N. Celli et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma Hepatology 42 2005 27 34
7. A.E. Holland, E.M. Hecht, and W.Y. Hahn et al. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver Radiology 237 2005 938 944
8. K.S. Lim, and C.H. Tan Diffusion-weighted MRI of adult male pelvic cancers Clin Radiol 67 2012 899 908
9. D.M. Koh, and D.J. Collins Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 188 2007 1622 1635
10. B. Taouli, and D.M. Koh Diffusion-weighted MR imaging of the liver Radiology 254 2010 47 66
11. D.M. Koh, T. Takahara, Y. Imai, and D.J. Collins Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body Magn Reson Med Sci 6 2007 211 224
12. W.B. Coleman Mechanisms of human hepatocarcinogenesis Curr Mol Med 3 2003 573 588
13. S.C. Efremidis, and P. Hytiroglou The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation Eur Radiol 12 2002 753 764
14. T. Parikh, S.J. Drew, and V.S. Lee et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging Radiology 246 2008 812 822
15. J.E. Kim, S.H. Kim, and S.J. Lee et al. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging AJR Am J Roentgenol 196 2011 W758 W765
16. K. Nasu, Y. Kuroki, and T. Tsukamoto et al. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade AJR Am J Roentgenol 193 2009 438 444
17. P.J. Xu, F.H. Yan, and J.H. Wang et al. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver J Comput Assist Tomogr 34 2010 506 512
18. A. Muhi, T. Ichikawa, and U. Motosugi et al. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma J Magn Reson Imaging 30 2009 1005 1011
19. U. Motosugi, T. Ichikawa, and H. Sou et al. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging Radiology 256 2010 151 158
20. V. Vandecaveye, F. De Keyzer, and C. Verslype et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma Eur Radiol 19 2009 2456 2466
21. B. Taouli, A.J. Tolia, and M. Losada et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience AJR Am J Roentgenol 189 2007 799 806
22. A.Y. Kim, Y.K. Kim, and M.W. Lee et al. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis Acta Radiol 53 2012 830 838
23. P.J. Xu, F.H. Yan, and J.H. Wang et al. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis J Magn Reson Imaging 29 2009 341 349
24. K. Sano, T. Ichikawa, and U. Motosugi et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging Radiology 261 2011 834 844
25. M.H. Lee, S.H. Kim, and M.J. Park et al. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease AJR Am J Roentgenol 197 2011 W868 W875
26. M.J. Park, Y.K. Kim, and M.W. Lee et al. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns Radiology 264 2012 761 770
27. Y.K. Kim, W.J. Lee, and M.J. Park et al. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC Radiology 265 2012 104 114
28. D. Le Bihan, E. Breton, and D. Lallemand et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders Radiology 161 1986 401 407
29. D. Le Bihan, E. Breton, and D. Lallemand et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging Radiology 168 1988 497 505
30. I. Yamada, W. Aung, and Y. Himeno et al. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging Radiology 210 1999 617 623
31. M. Lewin, L. Fartoux, and A. Vignaud et al. The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study Eur Radiol 21 2011 281 290
32. J. Haratake, S. Takeda, and T. Kasai et al. Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma Cancer 72 1993 1178 1183
33. G.Y. Lauwers, B. Terris, and U.J. Balis et al. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index Am J Surg Pathol 26 2002 25 34
34. C. An, M.S. Park, and H.M. Jeon et al. Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI Eur Radiol 22 2012 1701 1708
35. A. Nishie, T. Tajima, and Y. Asayama et al. Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma Eur J Radiol 80 2011 e29 e33
36. S.H. Heo, Y.Y. Jeong, and S.S. Shin et al. Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor Korean J Radiol 11 2010 295 303
37. M. Nakanishi, M. Chuma, and S. Hige et al. Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma Ann Surg Oncol 19 2012 1302 1309
38. R. Salem, R. Lewandowski, and C. Roberts et al. Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis J Vasc Interv Radiol 15 2004 335 345
39. O.A. Catalano, G. Choy, and A. Zhu et al. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging Radiology 254 2010 154 162
40. J.S. Yu, J.J. Chung, and J.H. Kim et al. Limited value of diffusion-weighted MR imaging for differentiating bland from malignant portal venous thrombi Radiology 256 2010 673 674 author reply 4.41
41. R.T. Poon, S.T. Fan, and I.O. Ng et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma Cancer 89 2000 500 507
42. J.S. Yu, J.J. Chung, and J.H. Kim et al. Detection of small intrahepatic metastases of hepatocellular carcinomas using diffusion-weighted imaging: comparison with conventional dynamic MRI Magn Reson Imaging 7 2011 985 992
43. D.E. Ramsey, L.Y. Kernagis, and M.C. Soulen et al. Chemoembolization of hepatocellular carcinoma J Vasc Interv Radiol 13 2002 S211 S221
44. J.A. Vossen, M. Buijs, and I.R. Kamel Assessment of tumor response on MR imaging after locoregional therapy Tech Vasc Interv Radiol 9 2006 125 132
45. S.H. Hwang, J.S. Yu, and J. Chung et al. Transient hepatic attenuation difference (THAD) following transcatheter arterial chemoembolization for hepatic malignancy: changes on serial CT examinations Eur Radiol 18 2008 1596 1603
46. A. Afaq, A. Andreou, and D.M. Koh Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how? Cancer Imaging 10 Spec no A 2010 S179 S188
47. I.R. Kamel, D.A. Bluemke, and J. Eng et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma J Vasc Interv Radiol 17 2006 505 512
48. H. Sahin, M. Harman, and C. Cinar et al. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging J Vasc Interv Radiol 23 2012 241 247
49. I.R. Kamel, D.A. Bluemke, and D. Ramsey et al. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma AJR Am J Roentgenol 181 2003 708 710
50. L. Mannelli, S. Kim, and C.H. Hajdu et al. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver AJR Am J Roentgenol 193 2009 1044 1052
51. C.Y. Chen, C.W. Li, and Y.T. Kuo et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants - initial experience Radiology 239 2006 448 456
52. I.R. Kamel, E. Liapi, and D.K. Reyes et al. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging Radiology 250 2009 466 473
53. S. Goshima, M. Kanematsu, and H. Kondo et al. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? J Magn Reson Imaging 27 2008 834 839
54. J.S. Yu, J.H. Kim, and J.J. Chung et al. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas J Magn Reson Imaging 30 2009 153 160
55. J.E. Goin, R. Salem, and B.I. Carr et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis J Vasc Interv Radiol 16 2005 195 203
56. A. Al-Kalbani, and Y. Kamel Y-90 microshperes in the treatment of unresectable hepatocellular 1carcinoma Saudi J Gastroenterol 14 2008 90 92
57. J. Deng, F.H. Miller, and T.K. Rhee et al. Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization J Vasc Interv Radiol 17 2006 1195 1200
58. T.K. Rhee, N.K. Naik, and J. Deng et al. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging J Vasc Interv Radiol 19 2008 1180 1186
59. I.R. Kamel, D.K. Reyes, and E. Liapi et al. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma J Vasc Interv Radiol 18 2007 49 56
60. J.M. Llovet, S. Ricci, and V. Mazzaferro et al. Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390